Stocks
Funds
Screener
Sectors
Watchlists
NURO

NURO - NeuroMetrix Inc Stock Price, Fair Value and News

$4.58 
Market Closed

NURO Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

NURO Price Action

NURO RSI Chart

NURO Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

NURO Valuation

NURO Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

NURO Fundamentals

NURO Revenue

NURO Earnings

NURO Profitability

NURO Investor Care

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
20245.3M4.4M3.8M3.0M
20237.7M7.2M6.4M5.9M
20228.4M8.3M8.2M8.3M
20217.4M8.2M8.2M8.3M
20206.5M6.5M6.5M7.4M
201917.0M14.6M13.0M10.1M
201817.5M17.0M17.1M16.0M
201714.1M15.7M15.9M17.1M
20168.3M9.7M11.0M12.0M
20155.5M5.3M6.0M7.3M
20145.2M5.4M5.5M5.5M
20136.9M5.8M5.4M5.3M
20129.6M9.2M8.4M7.6M
201113.2M12.0M11.1M10.4M
2010022.1M18.0M13.9M
200900026.1M
NURO
NeuroMetrix, Inc., a commercial stage neurotechnology company, engages in designing, building, and marketing medical devices that stimulate and analyze nerve response for diagnostic and therapeutic purposes in the United States, Europe, Japan, China, the Middle East, and Mexico. Its primary marketed products include DPNCheck, a nerve conduction test that is used to evaluate peripheral neuropathies, such as diabetic peripheral neuropathy; Quell, a wearable device for symptomatic relief and management of chronic pain; and ADVANCE system, a platform for the performance of nerve conduction studies. The company offers its products to managed care organizations, endocrinologists, podiatrists, and primary care physicians; occupational health, primary care, internal medicine, orthopedic, and hand surgeons; and pain medicine physicians, neurologists, physical medicine and rehabilitation physicians, and neurosurgeons. NeuroMetrix, Inc. was incorporated in 1996 and is headquartered in Woburn, Massachusetts.
 CEO
 WEBSITEneurometrix.com
 SECTORHealthcare
 INDUSTRYMedical Devices
 EMPLOYEES27